Literature DB >> 13679089

Kava lactones and the kava-kava controversy.

Peter A Whitton1, Andrew Lau, Alicia Salisbury, Julie Whitehouse, Christine S Evans.   

Abstract

Kava-kava is a traditional beverage of the South Pacific islanders and has had centuries of use without major side effects. Standardised extracts of kava-kava produced in Europe have led to many serious health problems and even to death. The extraction process (aqueous vs. acetone in the two types of preparations) is responsible for the difference in toxicity as extraction of glutathione in addition to the kava lactones is important to provide protection against hepatotoxicity. The Michael reaction between glutathione and kava lactones, resulting in opening of the lactone ring, reduces the side effects of the kava kava extracts. This protective activity was demonstrated using Acanthamoebae castellanii in which 100% cell death occurred with 100 mg ml(-1) kava lactones alone, and 40% cell death with a mixture of 100 mg ml (-1)glutathione and 100 mg ml (-1) kava lactones. A comparison of kava lactone toxicity with other pharmaceutical products is discussed and recommendations made for safe usage of kava-kava products

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679089     DOI: 10.1016/s0031-9422(03)00381-9

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  22 in total

Review 1.  Biological reactive intermediates (BRIs) formed from botanical dietary supplements.

Authors:  Birgit M Dietz; Judy L Bolton
Journal:  Chem Biol Interact       Date:  2010-10-21       Impact factor: 5.192

2.  Botanical dietary supplements gone bad.

Authors:  Birgit Dietz; Judy L Bolton
Journal:  Chem Res Toxicol       Date:  2007-03-16       Impact factor: 3.739

3.  Immunohistochemical analysis of expressions of hepatic cytochrome P450 in F344 rats following oral treatment with kava extract.

Authors:  Natasha P Clayton; Katsuhiko Yoshizawa; Grace E Kissling; Leo T Burka; Po-Chuen Chan; Abraham Nyska
Journal:  Exp Toxicol Pathol       Date:  2006-10-23

4.  In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes.

Authors:  Bill J Gurley; Stephanie F Gardner; Martha A Hubbard; D Keith Williams; W Brooks Gentry; Ikhlas A Khan; Amit Shah
Journal:  Clin Pharmacol Ther       Date:  2005-05       Impact factor: 6.875

5.  Liver toxicity and carcinogenicity in F344/N rats and B6C3F1 mice exposed to Kava Kava.

Authors:  Mamta Behl; Abraham Nyska; Rajendra S Chhabra; Gregory S Travlos; Laurene M Fomby; Barney R Sparrow; Milton R Hejtmancik; Po C Chan
Journal:  Food Chem Toxicol       Date:  2011-08-18       Impact factor: 6.023

6.  Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents.

Authors:  Jun Wang; Weiyue Qu; Harry C Bittenbender; Qing X Li
Journal:  J Food Sci Technol       Date:  2013-06-25       Impact factor: 2.701

7.  Dihydromethysticin kavalactone induces apoptosis in osteosarcoma cells through modulation of PI3K/Akt pathway, disruption of mitochondrial membrane potential and inducing cell cycle arrest.

Authors:  Jun-Qi Dai; Yi-Gang Huang; Ai-Na He
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

8.  Efficacy of extracting solvents to chemical components of kava (Piper methysticum) roots.

Authors:  Tran Dang Xuan; Masakazu Fukuta; Ao Chang Wei; Abdelnaser Abdelghany Elzaawely; Tran Dang Khanh; Shinkichi Tawata
Journal:  J Nat Med       Date:  2007-11-28       Impact factor: 2.343

9.  Kava, a tonic for relieving the irrational development of natural preventive agents.

Authors:  Rajesh Agarwal; Gagan Deep
Journal:  Cancer Prev Res (Phila)       Date:  2008-11

10.  A re-evaluation of kava (Piper methysticum).

Authors:  E Ernst
Journal:  Br J Clin Pharmacol       Date:  2007-06-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.